• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连接臂延长对 4-烷基-5-芳基-1,2,4-三唑-3-硫酮衍生物对 VGSC 亲和力和抗惊厥活性的影响。

Effect of Linker Elongation on the VGSC Affinity and Anticonvulsant Activity among 4-Alkyl-5-aryl-1,2,4-triazole-3-thione Derivatives.

机构信息

Department of Pharmacology, Faculty of Health Sciences, Medical University of Lublin, Radziwiłłowska 11, 20-080 Lublin, Poland.

Department of Clinical Genetics, Faculty of Medicine, Medical University of Lublin, Radziwiłłowska 11, 20-080 Lublin, Poland.

出版信息

Molecules. 2023 Jul 7;28(13):5287. doi: 10.3390/molecules28135287.

DOI:10.3390/molecules28135287
PMID:37446948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10343781/
Abstract

The main aim of the current project was to investigate the effect of the linker size in 4-alkyl-5-aryl-1,2,4-triazole-3-thione derivatives, known as a group of antiepileptic drug candidates, on their affinity towards voltage-gated sodium channels (VGSCs). The rationale of the study was based both on the SAR observations and docking simulations of the interactions between the designed ligands and the binding site of human VGSC. HYDE docking scores, which describe hydrogen bonding, desolvation, and hydrophobic effects, obtained for 5-[(3-chlorophenyl)ethyl]-4-butyl/hexyl-1,2,4-triazole-3-thiones, justified their beneficial sodium channel blocking activity. The results of docking simulations were verified using a radioligand binding assay with [H]batrachotoxin. Unexpectedly, although the investigated triazole-based compounds acted as VGSC ligands, their affinities were lower than those of the respective analogs containing shorter alkyl linkers. Since numerous sodium channel blockers are recognized as antiepileptic agents, the obtained 1,2,4-triazole derivatives were examined for antiepileptic potential using an experimental model of tonic-clonic seizures in mice. Median effective doses (ED) of the compounds examined in MES test reached 96.6 ± 14.8 mg/kg, while their median toxic doses (TD), obtained in the rotarod test, were even as high as 710.5 ± 47.4 mg/kg.

摘要

本研究旨在探讨 4-烷基-5-芳基-1,2,4-三唑-3-硫酮衍生物(已知是一组抗癫痫候选药物)中连接子大小对其与电压门控钠离子通道(VGSCs)亲和力的影响。研究的依据是基于设计配体与人类 VGSC 结合位点相互作用的 SAR 观察和对接模拟。对于 5-[(3-氯苯基)乙基]-4-丁基/己基-1,2,4-三唑-3-硫酮获得的 HYDE 对接评分,描述了氢键、去溶剂化和疏水相互作用,证明了它们具有有益的钠通道阻断活性。对接模拟的结果使用 [H]batrachotoxin 放射性配体结合测定法进行了验证。出乎意料的是,尽管研究的三唑基化合物作为 VGSC 配体起作用,但它们的亲和力低于具有较短烷基连接子的相应类似物。由于许多钠离子通道阻滞剂被认为是抗癫痫药物,因此使用小鼠强直-阵挛性癫痫发作的实验模型来检查获得的 1,2,4-三唑衍生物的抗癫痫潜力。在 MES 测试中检查的化合物的中位数有效剂量(ED)达到 96.6±14.8mg/kg,而在旋转棒测试中获得的中位数毒性剂量(TD)甚至高达 710.5±47.4mg/kg。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdda/10343781/28d20ef64e2a/molecules-28-05287-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdda/10343781/6fc7bacef2bf/molecules-28-05287-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdda/10343781/a037512bef99/molecules-28-05287-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdda/10343781/db05b9216680/molecules-28-05287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdda/10343781/28d20ef64e2a/molecules-28-05287-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdda/10343781/6fc7bacef2bf/molecules-28-05287-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdda/10343781/a037512bef99/molecules-28-05287-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdda/10343781/db05b9216680/molecules-28-05287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdda/10343781/28d20ef64e2a/molecules-28-05287-sch001.jpg

相似文献

1
Effect of Linker Elongation on the VGSC Affinity and Anticonvulsant Activity among 4-Alkyl-5-aryl-1,2,4-triazole-3-thione Derivatives.连接臂延长对 4-烷基-5-芳基-1,2,4-三唑-3-硫酮衍生物对 VGSC 亲和力和抗惊厥活性的影响。
Molecules. 2023 Jul 7;28(13):5287. doi: 10.3390/molecules28135287.
2
Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies.基于 1,2,4-三氮唑的抗惊厥药物候选物的开发作用于电压门控钠离子通道。来自体内、体外和计算研究的见解。
Eur J Pharm Sci. 2019 Mar 1;129:42-57. doi: 10.1016/j.ejps.2018.12.018. Epub 2018 Dec 28.
3
Development of new chiral 1,2,4-triazole-3-thiones and 1,3,4-thiadiazoles with promising in vivo anticonvulsant activity targeting GABAergic system and voltage-gated sodium channels (VGSCs).开发新型手性 1,2,4-三唑-3-硫酮和 1,3,4-噻二唑,具有针对 GABA 能系统和电压门控钠离子通道(VGSCs)的有前途的体内抗惊厥活性。
Bioorg Chem. 2024 Oct;151:107662. doi: 10.1016/j.bioorg.2024.107662. Epub 2024 Jul 18.
4
Studies on the anticonvulsant activity of 4-alkyl-1,2,4-triazole-3-thiones and their effect on GABAergic system.4-烷基-1,2,4-三唑-3-硫酮的抗惊厥活性及其对γ-氨基丁酸能系统影响的研究。
Eur J Med Chem. 2014 Oct 30;86:690-9. doi: 10.1016/j.ejmech.2014.09.034. Epub 2014 Sep 16.
5
Preclinical evaluation of 1,2,4-triazole-based compounds targeting voltage-gated sodium channels (VGSCs) as promising anticonvulsant drug candidates.基于 1,2,4-三唑的化合物靶向电压门控钠离子通道(VGSCs)的临床前评价作为有前途的抗惊厥药物候选物。
Bioorg Chem. 2020 Jan;94:103355. doi: 10.1016/j.bioorg.2019.103355. Epub 2019 Oct 17.
6
Anticonvulsant and neurotoxic effects of a novel 1,2,4-triazole-3-thione derivative (TPF-34) and its isobolographic interaction profile with classical antiepileptic drugs in mice.新型 1,2,4-三唑-3-硫酮衍生物(TPF-34)的抗惊厥和神经毒性作用及其与经典抗癫痫药物的协同作用在小鼠体内的研究。
Pharmacol Rep. 2020 Feb;72(1):87-95. doi: 10.1007/s43440-019-00044-7. Epub 2019 Dec 20.
7
Anticonvulsant Effectiveness and Neurotoxicity Profile of 4-butyl-5-[(4-chloro-2-methylphenoxy)methyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (TPL-16) in Mice.4-丁基-5-[(4-氯-2-甲基苯氧基)甲基]-2,4-二氢-3H-1,2,4-三唑-3-硫酮(TPL-16)在小鼠中的抗惊厥作用和神经毒性特征。
Neurochem Res. 2021 Feb;46(2):396-410. doi: 10.1007/s11064-020-03175-z. Epub 2020 Nov 18.
8
Effect of Chronic Administration of 5-(3-chlorophenyl)-4-Hexyl-2,4 -Dihydro-3-1,2,4-Triazole-3-Thione (TP-315)-A New Anticonvulsant Drug Candidate-On Living Organisms.慢性给予 5-(3-氯苯基)-4-己基-2,4-二氢-3-1,2,4-三唑-3-硫酮(TP-315)-一种新型抗惊厥候选药物对生物机体的影响。
Int J Mol Sci. 2021 Mar 25;22(7):3358. doi: 10.3390/ijms22073358.
9
Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3-1,2,4-triazole-3-thione - a novel anticonvulsant drug candidate.新型抗惊厥候选药物5-(3-氯苯基)-4-己基-2,4-二氢-3H-1,2,4-三唑-3-硫酮的作用分子机制及安全性
Int J Med Sci. 2017 Jul 18;14(8):741-749. doi: 10.7150/ijms.20001. eCollection 2017.
10
Effect of 4-(4-bromophenyl)-5-(3-chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.4-(4-溴苯基)-5-(3-氯苯基)-2,4-二氢-3H-1,2,4-三唑-3-硫酮对不同经典抗癫痫药物在小鼠最大电休克致惊厥模型中抗惊厥作用的影响。
Eur J Pharmacol. 2012 Sep 5;690(1-3):99-106. doi: 10.1016/j.ejphar.2012.06.023. Epub 2012 Jun 23.

引用本文的文献

1
Design, Synthesis, and Pharmacological Activity of the -(4-(1H-1,2,4-Triazol-1-yl)phenyl)-substituted-amide Derivatives.-(4-(1H-1,2,4-三唑-1-基)苯基)取代酰胺衍生物的设计、合成及药理活性
Molecules. 2025 Aug 18;30(16):3400. doi: 10.3390/molecules30163400.

本文引用的文献

1
Structural mapping of Na1.7 antagonists.钠离子通道 1.7 拮抗剂的结构映射。
Nat Commun. 2023 Jun 3;14(1):3224. doi: 10.1038/s41467-023-38942-3.
2
An Important Potential Anti-Epileptic/Anticonvulsant Active Group: A Review of 1,2,4-Triazole Groups and Their Action.一个重要的潜在抗癫痫/抗惊厥活性基团:1,2,4-三唑基团及其作用综述。
Drug Res (Stuttg). 2022 Mar;72(3):131-138. doi: 10.1055/a-1670-6992. Epub 2021 Nov 10.
3
Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction.抗惊厥药物的反应性代谢产物及将药物不良反应降至最低的方法。
Eur J Med Chem. 2021 Dec 15;226:113890. doi: 10.1016/j.ejmech.2021.113890. Epub 2021 Oct 2.
4
Effects of an educational comic book on epilepsy-related knowledge, attitudes and practices among schoolchildren in Madagascar.一本教育漫画书对马达加斯加学童癫痫相关知识、态度及行为的影响。
Epilepsy Res. 2021 Oct;176:106737. doi: 10.1016/j.eplepsyres.2021.106737. Epub 2021 Aug 9.
5
Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies.耐药性癫痫的临床管理:当前策略综述
Neuropsychiatr Dis Treat. 2021 Jul 12;17:2229-2242. doi: 10.2147/NDT.S256699. eCollection 2021.
6
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies.药物抵抗性癫痫:现有及新兴治疗方法概述
Front Neurol. 2021 Jun 22;12:674483. doi: 10.3389/fneur.2021.674483. eCollection 2021.
7
C-11, a New Antiepileptic Drug Candidate: Evaluation of the Physicochemical Properties and Impact on the Protective Action of Selected Antiepileptic Drugs in the Mouse Maximal Electroshock-Induced Seizure Model.C-11,一种新型抗癫痫候选药物:在最大电休克诱导的小鼠癫痫发作模型中评估其物理化学性质以及对选定抗癫痫药物的保护作用的影响。
Molecules. 2021 May 24;26(11):3144. doi: 10.3390/molecules26113144.
8
PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA.PLIP 2021:将蛋白质-配体相互作用分析器的范围扩展到 DNA 和 RNA。
Nucleic Acids Res. 2021 Jul 2;49(W1):W530-W534. doi: 10.1093/nar/gkab294.
9
Effect of Chronic Administration of 5-(3-chlorophenyl)-4-Hexyl-2,4 -Dihydro-3-1,2,4-Triazole-3-Thione (TP-315)-A New Anticonvulsant Drug Candidate-On Living Organisms.慢性给予 5-(3-氯苯基)-4-己基-2,4-二氢-3-1,2,4-三唑-3-硫酮(TP-315)-一种新型抗惊厥候选药物对生物机体的影响。
Int J Mol Sci. 2021 Mar 25;22(7):3358. doi: 10.3390/ijms22073358.
10
Anticonvulsant Effectiveness and Neurotoxicity Profile of 4-butyl-5-[(4-chloro-2-methylphenoxy)methyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione (TPL-16) in Mice.4-丁基-5-[(4-氯-2-甲基苯氧基)甲基]-2,4-二氢-3H-1,2,4-三唑-3-硫酮(TPL-16)在小鼠中的抗惊厥作用和神经毒性特征。
Neurochem Res. 2021 Feb;46(2):396-410. doi: 10.1007/s11064-020-03175-z. Epub 2020 Nov 18.